Screener
Capricor Therapeutics CAPR Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Capricor Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The source filing: Capricor Therapeutics’s 10-Q, filed May 13, 2026. Open the filing →
- Filed
- May 13, 2026, 5:20 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-060382
FAQ
- What is Capricor Therapeutics's shares (diluted)?
- Capricor Therapeutics (CAPR) reported shares (diluted) of 57.4M in Q1 2026.
- How has Capricor Therapeutics's shares (diluted) changed year-over-year?
- Capricor Therapeutics's shares (diluted) increased by 25.9% year-over-year, from 45.6M to 57.4M.
- What is the long-term trend for Capricor Therapeutics's shares (diluted)?
- Over 4 years (2021 to 2025), Capricor Therapeutics's shares (diluted) has grown at a 19.1% compound annual growth rate (CAGR), from 91.3M to 183.5M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.
Ask your AI about Capricor Therapeutics's shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude